Hsa-miR-1843 inhibitor
Hsa-miR-1843 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.
Product Specifications
UNSPSC
12352208
Target
MicroRNA
Type
Oligonucleotides
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hsa-mir-1843-inhibitor.html
Solubility
10 mM in H2O
Molecular Weight
5989.05
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2259-07-ML550 100 µL
CD8 (Leu2 T lymphocyte antigen, MAL, OKT8 T Cell antigen, p32, T cell antigen Leu2, T cell surface glycoprotein CD8 alpha, Suppressor/Cytotoxic T cell) (MaxLight 550) discontinued
Sign In for Pricing
View Details RC212989L4V 200 µL
CNGB3 (NM_019098) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
MBS2558367-01 20 Tests
Anti-Human CD11a Monoclonal Antibody (FITC Conjugated)
Sign In for Pricing
View Details